This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Novartis Ag, Add Advanced Drug Delivery Technologies Ltd.. Active years: 2001-2022.
Location History:
- Basel, CH (2001 - 2015)
- Basel, DE (2022)
Company Filing History:
Years Active: 2001-2022
Title: Manfred Kohlmeyer: Innovator in Pharmaceutical Technology
Introduction
Manfred Kohlmeyer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of oral preparations with controlled release mechanisms. With a total of 5 patents to his name, Kohlmeyer has demonstrated a commitment to advancing drug delivery systems.
Latest Patents
Kohlmeyer's latest patents focus on innovative pharmaceutical pellets designed for controlled release of active ingredients. One of his key inventions involves a spherical core containing an active ingredient with a smooth surface, coated to control the release in a pH-independent manner. This design allows for a lag phase of 60 to 840 minutes, during which only 5 wt. % or less of the active ingredient is released. After this lag phase, the release rate can vary between 3 and 25 wt. % per hour, providing a flexible and effective drug delivery solution.
Career Highlights
Throughout his career, Manfred Kohlmeyer has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Add Advanced Drug Delivery Technologies Ltd. His experience in these organizations has contributed to his expertise in drug formulation and delivery technologies.
Collaborations
Kohlmeyer has collaborated with esteemed colleagues such as Robert Frank Wagner and Yoshimitsu Katakuse. These partnerships have further enriched his work and have led to advancements in pharmaceutical innovations.
Conclusion
Manfred Kohlmeyer stands out as a significant figure in the realm of pharmaceutical inventions. His innovative approaches to drug delivery systems continue to impact the industry positively.
